A Milestone in Evidence-Based Nicotine Regulation: FDA’s Environmental Assessment for Nicotine Pouches

NewsLeave a comment

The U.S. Food and Drug Administration’s recent programmatic environmental assessment for nicotine pouch products may represent one of the more important yet underexamined developments in modern nicotine regulation. While much public attention surrounding nicotine governance focuses on toxicology, youth access, and population health outcomes, the FDA’s latest findings introduce another increasingly relevant dimension into the…

Nicotine Summit USA 2026: Is Policy Finally Catching Up to Science?

NewsLeave a comment

The discussions emerging from Nicotine Summit USA 2026 suggest a growing recognition that nicotine policy may be entering a new phase, one in which regulatory systems are increasingly being challenged to reconcile long-standing public health objectives with evolving scientific evidence, consumer behavior, and market realities. As highlighted in recent reporting and commentary surrounding the Summit,…

Brazil’s 4mg Pharmaceutical Model: What ANVISA’s Direction Could Mean for Innovation, Consumers, and Latin America’s Regulatory Future

NewsLeave a comment

Brazil is increasingly positioning itself as one of Latin America’s most consequential regulatory bellwethers in the debate over novel nicotine products. As policymakers across the region assess how emerging nicotine categories should be governed, Brazil’s pharmaceutical-style approach, centered around strict dosage controls such as a 4mg cap, signals a distinctly cautious pathway. For GINN LatAm,…

Portugal’s Challenge to the UK Tobacco Ban: A New Test for Post-Brexit Regulatory Sovereignty

News, RegulationsLeave a comment

Portugal’s recent accusation that the United Kingdom’s proposed tobacco ban may violate post-Brexit legal commitments has introduced a new dimension into nicotine and tobacco policy debate, one that extends beyond domestic public health objectives and into the increasingly complex intersection of sovereignty, trade law, and international regulatory coherence. While the immediate issue centers on tobacco…

Nicotine Analogs and the Next Regulatory Frontier: Emerging Questions for Science, Policy, and Product Governance

News, RegulationsLeave a comment

Inspired by commentary from Chris Allen on discussions surrounding the 10th Keller and Heckman Symposium. As global nicotine regulation continues to evolve, one of the more technically complex and strategically significant emerging issues is the rise of nicotine analogs, compounds structurally related to nicotine that may increasingly challenge existing regulatory definitions, product classifications, and enforcement…

Argentina Rewrites Its Nicotine Policy Framework: From Prohibition to Regulatory Integration

News, RegulationsLeave a comment

Argentina has formally entered a new era in nicotine product governance. With the publication of Resolution 549/2026, the Ministry of Health has replaced a longstanding prohibition-centered framework with a structured regulatory system for innovative nicotine products (INPs), including vaping products, heated tobacco products, and nicotine pouches. Framed domestically as the “fin de la prohibición,” Argentine…

France’s Nicotine Pouch Ban and Europe’s Regulatory Divide: What It Reveals About EU Policy Fragmentation

News, RegulationsLeave a comment

France’s recent move to prohibit nicotine pouches has intensified debate across Europe over how emerging nicotine products should be governed within the European Union’s legal and regulatory architecture. The decision has drawn attention not only because of its domestic implications, but because it highlights a broader and increasingly visible challenge within Europe: regulatory fragmentation between…

From Pilot to Precedent: How FDA’s Nicotine Pouch Program May Reshape Premarket Review

News, RegulationsLeave a comment

Inspired by analysis from Andrew Mooney of Broughton Group and broader discussions emerging from ATNF 2026. The U.S. Food and Drug Administration’s recent nicotine pouch pilot program may prove to be one of the most consequential regulatory developments for reduced-risk nicotine products in years, not because it lowered standards, but because it demonstrated that speed…

Emerging Evidence on Nicotine Pouch Use: Insights from Recent U.S. Data

News, ScienceLeave a comment

Recent research published in the American Journal of Preventive Medicine provides updated evidence on nicotine pouch use among adults in the United States, offering new insights into usage patterns, population trends, and potential regulatory considerations. The study, Nicotine Pouch Use Among U.S. Adults in 2023 and 2024, examines nationally representative data to assess how use…

Taxation and Market Surveillance: Navigating Policy Complexity in the EU and Beyond

News, RegulationsLeave a comment

At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a deep dive session examining how taxation frameworks and market surveillance systems are shaping the regulation and development of alternative nicotine products across the EU and beyond. The session was moderated by Ciprian Boboi and featured contributions from Tomasz Płaska, Leonhard Kipphan, and Lorenzo…